Cardlytics CDLX Estimates

NASDAQ CDLX
$4.27 +0.53 (+14.17%)
At close: Sep 9, 2026 · 4:00 PM EDT
Analyst Estimates

Cardlytics, Inc. Revenue Estimates

Periods 18
Next Period Q3 26
Consensus 38.00 M

Analysts expect Cardlytics, Inc. to report revenue of 38.00 M for Q3 26, against a range of 35.73 M to 40.27 M. The most recent reported quarter, Q2 26, came in at 36.88 M, a 6.0% beat against the 34.80 M consensus.

Metric Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28
Reported (Actual) 67.06 M74.00 M61.90 M63.25 M52.03 M56.09 M34.32 M36.88 M--------
High Estimate 63.51 M65.05 M62.92 M65.94 M54.51 M54.74 M42.20 M37.60 M40.27 M43.94 M35.65 M40.55 M36.68 M42.20 M32.09 M35.79 M
Low Estimate 55.13 M58.87 M57.36 M56.73 M51.30 M47.09 M35.94 M32.00 M35.73 M40.40 M31.60 M35.32 M33.68 M35.76 M27.07 M32.42 M
Consensus Estimate 59.32 M61.96 M60.14 M61.33 M52.90 M50.91 M39.07 M34.80 M38.00 M42.17 M33.62 M37.94 M35.18 M38.98 M29.58 M34.11 M
Analyst Estimates

Cardlytics, Inc. Earnings Per Share (EPS) Estimates

Periods 18
Next Period Q3 26
Consensus -2.00

Analysts expect Cardlytics, Inc. to report earnings per share of -2.00 for Q3 26, against a range of -2.09 to -1.91. The most recent reported quarter, Q2 26, came in at -2.58, a 7.9% miss against the -2.39 consensus.

Metric Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28
Reported (Actual) -29.00-3.10-2.60-1.80-13.60-1.50-0.80-2.58--------
High Estimate -5.04-4.20-4.74-3.42-3.10-1.94-3.55-2.21-1.91-1.57-2.16-1.86-1.313.410.14-1.13
Low Estimate -5.98-4.88-5.12-3.90-3.70-2.28-4.15-2.57-2.09-1.79-2.54-2.02-1.533.090.12-1.25
Consensus Estimate -5.51-4.54-4.93-3.66-3.40-2.11-3.85-2.39-2.00-1.68-2.35-1.94-1.423.250.13-1.19